Submillisievert Multiphasic Coronary Computed Tomography Angiography for Pediatric Patients With Congenital Heart Diseases.


Journal

Circulation. Cardiovascular imaging
ISSN: 1942-0080
Titre abrégé: Circ Cardiovasc Imaging
Pays: United States
ID NLM: 101479935

Informations de publication

Date de publication:
02 2019
Historique:
entrez: 2 2 2019
pubmed: 2 2 2019
medline: 4 12 2019
Statut: ppublish

Résumé

The use of coronary computed tomography (CT) angiography in children with coronary artery anomalies is increasing. However, it remains technically demanding and the need to adapt acquisition parameters to a patient's cardiac characteristics has not yet been addressed. The aim of the study was to prospectively assess the feasibility of personalized multiphasic coronary CT angiography for pediatric patients. Fifty pediatric patients (mean age 6.1±4.9 years) with coronary artery anomalies underwent a coronary CT angiography on a wide detector single-source CT equipment. Fifteen different acquisition patterns were used to trigger the acquisition at the best theoretical moment within the cardiac cycle. The appropriate pattern was automatically selected based on the patient's heart rate and heart rate variability, derived from the patient's ECG. Two independent radiologists qualitatively evaluated images. All acquisitions fully answered the clinical question for a mean effective dose of 0.97±0.34 mSv. Image quality qualified as good or excellent in 94% of cases (47/50). No examination was considered as not assessable but 6% (3/50) were scored as adequate for diagnosis. For these 3 patients, motion artifacts were the main cause of average image quality. No significant visual differences were reported between the different coronary arteries (mean score of 3.6 on a 4-point scale). No correlation between image quality and cardiac parameters were reported ( r=-0.19 and r=0.00, respectively for heart rate and heart rate variability). Personalized multiphasic coronary CT angiography acquisitions could be performed with diagnostic quality for a dose equivalent of <4 months of natural background irradiation. URL: https://www.clinicaltrials.gov . Unique identifier: NCT03194763.

Sections du résumé

BACKGROUND
The use of coronary computed tomography (CT) angiography in children with coronary artery anomalies is increasing. However, it remains technically demanding and the need to adapt acquisition parameters to a patient's cardiac characteristics has not yet been addressed. The aim of the study was to prospectively assess the feasibility of personalized multiphasic coronary CT angiography for pediatric patients.
METHODS
Fifty pediatric patients (mean age 6.1±4.9 years) with coronary artery anomalies underwent a coronary CT angiography on a wide detector single-source CT equipment. Fifteen different acquisition patterns were used to trigger the acquisition at the best theoretical moment within the cardiac cycle. The appropriate pattern was automatically selected based on the patient's heart rate and heart rate variability, derived from the patient's ECG. Two independent radiologists qualitatively evaluated images.
RESULTS
All acquisitions fully answered the clinical question for a mean effective dose of 0.97±0.34 mSv. Image quality qualified as good or excellent in 94% of cases (47/50). No examination was considered as not assessable but 6% (3/50) were scored as adequate for diagnosis. For these 3 patients, motion artifacts were the main cause of average image quality. No significant visual differences were reported between the different coronary arteries (mean score of 3.6 on a 4-point scale). No correlation between image quality and cardiac parameters were reported ( r=-0.19 and r=0.00, respectively for heart rate and heart rate variability).
CONCLUSIONS
Personalized multiphasic coronary CT angiography acquisitions could be performed with diagnostic quality for a dose equivalent of <4 months of natural background irradiation.
CLINICAL TRIAL REGISTRATION
URL: https://www.clinicaltrials.gov . Unique identifier: NCT03194763.

Identifiants

pubmed: 30704282
doi: 10.1161/CIRCIMAGING.118.008348
doi:

Banques de données

ClinicalTrials.gov
['NCT03194763']

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e008348

Auteurs

Julien Le Roy (J)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Center, CHU Montpellier, France (J.L.R., M.V., H.A., K.L., P.A.).
PHYMEDEXP, University of Montpellier, CNRS, INSERM, CHU Montpellier, France (J.L.R., M.V., A.L., P.A.).

Hélène Vernhet Kovacsik (H)

Radiology Department, CHU Montpellier, France (H.V.K., H.Z.).

Hamid Zarqane (H)

Radiology Department, CHU Montpellier, France (H.V.K., H.Z.).

Marie Vincenti (M)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Center, CHU Montpellier, France (J.L.R., M.V., H.A., K.L., P.A.).
PHYMEDEXP, University of Montpellier, CNRS, INSERM, CHU Montpellier, France (J.L.R., M.V., A.L., P.A.).

Hamouda Abassi (H)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Center, CHU Montpellier, France (J.L.R., M.V., H.A., K.L., P.A.).

Kathleen Lavastre (K)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Center, CHU Montpellier, France (J.L.R., M.V., H.A., K.L., P.A.).

Thibault Mura (T)

Epidemiology and Clinical Research Department, University of Montpellier, INSERM, CHU Montpellier, France (T.M.).

Alain Lacampagne (A)

PHYMEDEXP, University of Montpellier, CNRS, INSERM, CHU Montpellier, France (J.L.R., M.V., A.L., P.A.).

Pascal Amedro (P)

Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Center, CHU Montpellier, France (J.L.R., M.V., H.A., K.L., P.A.).
PHYMEDEXP, University of Montpellier, CNRS, INSERM, CHU Montpellier, France (J.L.R., M.V., A.L., P.A.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH